Argenx
ARGX
#413
Rank
โ‚น5.642 T
Marketcap
โ‚น89,727
Share price
3.04%
Change (1 day)
16.39%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น151.67 Billion

According to Argenx 's latest financial reports the company's total liabilities are โ‚น151.67 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Argenx - Total liabilities on balance sheet (from 2021 to 2020)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚น26.52 B12.76%
2021-12-31โ‚น23.52 B-56.8%
2020-12-31โ‚น54.45 B58.6%
2019-12-31โ‚น34.33 B836.62%
2018-12-31โ‚น3.66 B53.46%
2017-12-31โ‚น2.38 B-25.11%
2016-12-31โ‚น3.18 B362.38%
2015-12-31โ‚น0.68 B-12.67%
2014-12-31โ‚น0.78 B102.7%
2013-12-31โ‚น0.38 B-14.29%
2012-12-31โ‚น0.45 B64.06%
2011-12-31โ‚น0.27 B129.19%
2010-12-31โ‚น0.12 B